Publications of FA Anderer
All genres
Journal Article (91)
41.
Journal Article
24 (1), pp. 59 - 71 (1986)
Activation of human monocyte and natural killer cell-mediated tumour cell killing by two dialysable thymic factors. Scandinavian Journal of Immunology 42.
Journal Article
64 (2), pp. 63 - 69 (1986)
Die Dopplungszeit des zirkulierenden CEA als individuelles prognostisches Kriterium bei Rezidivierung in Patienten mit gastrointestinalen Karzinomen: CEA time courses as an individual prognostic criterion of disease recurrence in patients with gastrointestinal cancer. Wiener Klinische Wochenschrift 43.
Journal Article
162 (1), pp. 11 - 22 (1986)
Phosphoprotein pp135 is an essential component of the nucleolus organizer region (NOR). Experimental Cell Research 44.
Journal Article
110 (51-52), pp. 1963 - 1968 (1985)
Carcinoembryonales Antigen: Diagnose der Tumorprogression bei gastrointestinalen Tumoren. Deutsche Medizinische Wochenschrift 45.
Journal Article
147 (2), pp. 396 - 400 (1985)
Immunodetection of nitrocellulose-adhesive proteins at the nanogram level after trinitrophenyl modification. Analytical Biochemistry 46.
Journal Article
28 (4), pp. 263 - 269 (1985)
Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. Journal of Surgical Oncology 47.
Journal Article
128 (1), pp. 34 - 39 (1985)
Monoclonal antibody-defined circulating human tumor-associated antigen with epitope shared by cytokeratins. Biochemical and Biophysical Research Communications 48.
Journal Article
149 (2), pp. 198 - 204 (1985)
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. The American Journal of Surgery 49.
Journal Article
63 (3), pp. 106 - 115 (1985)
The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Wiener Klinische Wochenschrift 50.
Journal Article
8 (1-2), pp. 35 - 45 (1985)
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control. Cancer Detection and Prevention 51.
Journal Article
6 (2), pp. 157 - 171 (1985)
Differentiation of disease recurrence in various primary malignancies using CEA slope analysis. Tumor Biology 52.
Journal Article
124 (3), pp. 933 - 938 (1984)
Cell fusion responsible for horizontal oncogenesis by human tumors in nude mice. Biochemical and Biophysical Research Communications 53.
Journal Article
109 (30), pp. 1141 - 1147 (1984)
Klinische Bedeutung des zirkulierenden tumorassoziierten Antigens CA 19-9 bei Karzinomen des Verdauungstraktesantigen (CEA). Deutsche Medizinische Wochenschrift 54.
Journal Article
139 (2), pp. 417 - 424 (1984)
Isolation and localization of phosphoprotein pp 135 in the nucleoli of various cell lines. European Journal of Biochemistry 55.
Journal Article
7 (4), pp. 279 - 288 (1984)
Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell lines. Cancer Detection and Prevention 56.
Journal Article
116 (1), pp. 106 - 112 (1983)
Localization of phosphoprotein PP 105 in cell lines of various species. Biochemical and Biophysical Research Communications 57.
Journal Article
762 (1), pp. 86 - 93 (1983)
Isolation and characterization of phosphoprotein pp 105 from simian virus 40-transformed mouse fibroblasts. Biochimica et Biophysica Acta: Molecular Cell Research 58.
Journal Article
6 (1-2), pp. 33 - 39 (1983)
Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease. Cancer Detection and Prevention 59.
Journal Article
6 (1-2), pp. 149 - 153 (1983)
Prognostic significance of preoperative carcinoembryonic antigen in stomach and colorectal cancer. Cancer Detection and Prevention 60.
Journal Article
106 (1), pp. 27 - 35 (1983)
In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors. Journal of Cancer Research and Clinical Oncology